FABP1 and cancer: Different stages of colorectal tumour development show varying levels of L-FABP expression, with a notable loss at the adenoma stage with larger adenomas exhibiting significantly decreased FABP1 staining, and immunoreactivity is significantly associated with poorly differentiated cancers.